The Analytical Core is a central resourse composed of three laboratories which facilitate the development and application of modern analytical methods to solve key problems encountered by the components of the Superfund Program. The first laboratory is the Superfund Analytical Laboratory which provides a range of instrument services relying heavily on mass spectrometry and chromatography. The second is the Accelerator Mass Spectrometry Facility with a new sample preparation laboratory in Davis and 2 AMS instruments at LLNL for ultra trace analysis of 14C and 36C1 as heavy isotopes. The third is the Molecular Structure Facility (MSF) which provides service for fee in the area of protein and nucleic acid chemistry. The Superfund Analytical Laboratory provides a wide range of analytical services for both small molecule and (in collaboration with MSF) for protein analysis. The analytical capability supporting both proteomics and metabolomics of the 'omics core 5' is located here. The core provides walk up instrumentation as well as service and research collaboration to the projects. It advances analytical technology for example by developing robotic sample clean up procedures, immunoaffinity chromatography and 'lab on a valve' approaches to sample preparation. It carries out bioassay driven fractionation of hazardous mixtures in collaboration with the projects and provides education for Superfund scientists in analytical chemistry. The LLNL component provides access to a variety of advanced instruments but will focus on the sub attomole (i.e. 10[-8]) sensitivity of Accelerator Mass Spectrometry (AMS) in support of a variety of projects using both 14C and 36C1 analysis. This technique for example for the first time allows monitoring of human metabolism of hazardous chemicals at environmentally realistic levels. Core scentists will educate Superfund researchers in the use and value of a full array of analytical techniques.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
2P42ES004699-19
Application #
6900559
Study Section
Special Emphasis Panel (ZES1-SET-A (S4))
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
19
Fiscal Year
2005
Total Cost
$438,427
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Burmistrov, Vladimir; Morisseau, Christophe; Pitushkin, Dmitry et al. (2018) Adamantyl thioureas as soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett 28:2302-2313
Philippat, Claire; Barkoski, Jacqueline; Tancredi, Daniel J et al. (2018) Prenatal exposure to organophosphate pesticides and risk of autism spectrum disorders and other non-typical development at 3 years in a high-risk cohort. Int J Hyg Environ Health 221:548-555
Tu, Ranran; Armstrong, Jillian; Lee, Kin Sing Stephen et al. (2018) Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. Sci Rep 8:5279
Wang, Weicang; Yang, Jun; Zhang, Jianan et al. (2018) Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation. Proc Natl Acad Sci U S A 115:5283-5288
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695

Showing the most recent 10 out of 1149 publications